AQR Capital Management
AXN

AQR Capital Management’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

AQR Capital Management’s Portfolio AXN Stock Details AXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-45,700
Closed -$80K – 2327
2015
Q2 		$80K Buy
+45,700
New +$81.3K ﹤0.01% 2179

Other funds holding AXN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CK
Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return

AQR Capital Management's AXN Position: Q3 2015 in Review

AQR Capital Management sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q3 2015, closing a stake of 45,700 shares — an estimated $80K sold.

AQR Capital Management first reported a position in AXN in Q2 2015 and held it in 1 quarter. The position peaked at $80K in Q2 2015. 10 funds tracked by Wall St. Rank hold AXN as of Q3 2015.

  • AQR Capital Management reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q3 2015 after selling out during the quarter.
  • AQR Capital Management sold 45,700 Aoxing Pharmaceutical Company Inc. shares in Q3 2015, an estimated $80K.
  • AQR Capital Management first reported a position in Aoxing Pharmaceutical Company Inc. in Q2 2015 and held it in 1 quarter.
  • AQR Capital Management's Aoxing Pharmaceutical Company Inc. position peaked at $80K in Q2 2015.
  • 10 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q3 2015.

Based on AQR Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.